HST Global, Inc. Files Q3 2024 10-Q

Ticker: HSTC · Form: 10-Q · Filed: Nov 22, 2024 · CIK: 797564

Hst Global, Inc. 10-Q Filing Summary
FieldDetail
CompanyHst Global, Inc. (HSTC)
Form Type10-Q
Filed DateNov 22, 2024
Risk Levellow
Pages15
Reading Time18 min
Key Dollar Amounts$0.001, $100,319, $625,005, $500,000, $100,000
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, pharmaceuticals

TL;DR

HST Global filed its Q3 10-Q. Financials are in.

AI Summary

HST Global, Inc. filed its 10-Q for the period ending September 30, 2024. The company, previously known as NT Holding Corp., ABSS Corp., and UNICO INC, is incorporated in Delaware and operates in the Pharmaceutical Preparations sector. Its principal business address is in Hampton, Virginia.

Why It Matters

This filing provides investors with the company's financial performance and operational status for the third quarter of 2024, crucial for understanding its current health and future prospects.

Risk Assessment

Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new disclosures.

Key Players & Entities

  • HST Global, Inc. (company) — Filer
  • NT HOLDING CORP. (company) — Former Company Name
  • ABSS CORP (company) — Former Company Name
  • UNICO INC (company) — Former Company Name
  • 20240930 (date) — Reporting Period End Date
  • 20241122 (date) — Filing Date

FAQ

What is the primary business of HST Global, Inc.?

HST Global, Inc. operates in the Pharmaceutical Preparations sector, with a Standard Industrial Classification code of [2834].

When is the fiscal year end for HST Global, Inc.?

The fiscal year end for HST Global, Inc. is December 31st.

What was HST Global, Inc. previously known as?

HST Global, Inc. was formerly known as NT HOLDING CORP., ABSS CORP, and UNICO INC.

What is the principal business address of HST Global, Inc.?

The principal business address is 150 RESEARCH DR., HAMPTON, VA 23666.

What period does this 10-Q filing cover?

This 10-Q filing covers the period ending September 30, 2024.

Filing Stats: 4,584 words · 18 min read · ~15 pages · Grade level 13.8 · Accepted 2024-11-21 17:32:25

Key Financial Figures

  • $0.001 — tock; 10,000,000 shares authorized, at $0.001 par value, no shares issued and outsta
  • $100,319 — h 31, 2024, the Company owed Mr. Howell $100,319 in notes payable. On April 24, 2024 ,
  • $625,005 — he transaction, the outstanding debt of $625,005 owed to Howell was purchased by HPAF an
  • $500,000 — well was purchased by HPAF and HGHI for $500,000. The debt was converted to equity and t
  • $100,000 — credit on May 1, 2024 in the amount of $100,000 with HPAF and HGHI. Executive Offices
  • $10,000 — by the Company agreed to pay Mr. Howell $10,000 per month for consulting services throu
  • $14,488 — 000 under the consulting agreement plus $14,488 in accumulated interest expenses. As p
  • $13,792 — 023. The Company realized a net loss of $13,792 for the quarter ended September 30, 202
  • $35,730 — r 30, 2024 as compared to a net loss of $35,730 for the quarter ended September 30, 202
  • $64,609 — 023. The Company realized a net loss of $64,609 for the nine months ended September 30,
  • $109,311 — r 30, 2024 as compared to a net loss of $109,311 for the nine months ended September 30,
  • $10,406 — cash balance on September 30, 2024 was $10,406 and $1,526 on September 30, 2023, respe
  • $1,526 — e on September 30, 2024 was $10,406 and $1,526 on September 30, 2023, respectively. F
  • $41,600 — for its operations through proceeds of $41,600 in 2024 from loans or advances from rel
  • $20,000 — s from related parties in the amount of $20,000. The Company does not currently have s

Filing Documents

Financial Statements

Financial Statements 4 Condensed Balance Sheets (unaudited) 4 Condensed Statements of Operations (unaudited) 5 Condensed Statements of Stockholders' Deficit (unaudited) 6 Condensed Statements of Cash Flow (unaudited) 7 Notes to Condensed Financial Statements (unaudited) 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 12 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 14 Item 4.

Controls and Procedures

Controls and Procedures 14 PART II OTHER INFORMATION 15 Item 1.

Legal Proceedings

Legal Proceedings 15 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 15 Item 3. Default Upon Senior Securities 15 Item 4. Mine Safety Disclosures 15 Item 5. Other Information 15 Item 6. Exhibits 15

Signatures

Signatures 15 Page 3

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS HST GLOBAL, INC. Condensed Balance Sheets At September 30, 2024 At December 31, 2023 (Unaudited) ASSETS Current Assets Cash and cash equivalents $ 10,406 $ 1,526 Total Current Assets 10,406 1,526 Other Assets Intellectual Property 1,270,664 - Total Other Assets 1,270,664 - Total Assets $ 1,281,070 $ 1,526 LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts payable and accrued expenses $ - $ 2,275 Accounts payable and accrued expenses - related parties - 480,000 Loans or advances from related party 41,600 98,319 Accrued related party interest 476 12,999 Total Current Liabilities 42,076 593,593 Total Liabilities 42,076 593,593 Stockholders' Deficit Preferred stock; 10,000,000 shares authorized, at $0.001 par value, no shares issued and outstanding as of September 30, 2024 and December 31, 2023 - - Common stock; 200,000,000 shares authorized, at $0.001 par value, 42,771,382 and 5,248,582 shares issued and outstanding as of September 30, 2024 and December 31, 2023 42,770 5,248 Additional paid-in capital 7,275,384 5,417,236 Accumulated deficit ( 6,079,160 ) ( 6,014,551 ) Total Stockholders' Deficit 1,238,994 ( 592,067 ) Total Liabilities and Stockholders' Deficit $ 1,281,070 $ 1,526 The accompanying notes are an integral part of these unaudited condensed financial statements Page 4 HST GLOBAL, INC. Condensed Statements of Operations (Unaudited) For the Three Months Ended September 30, 2024 For the Three Months Ended September 30, 2023 For the Nine Months Ended September 30, 2024 For the Nine Months Ended September 30, 2023 REVENUES $ - $ - $ - $ - OPERATING EXPENSES Consulting, related party - 30,000 30,000 90,000 General and administrative 13,400 4,368 32,643 15,433 Total Operating Expenses 13,400 34,368 62,643 105,433 Loss from Operations ( 13,400 )

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion should be read in conjunction with the information contained in the condensed financial statements of the Company and the notes thereto appearing elsewhere herein. As used in this report, the terms "Company", "we", "our", "us" and "HSTC" refer to HST Global, Inc. Preliminary Note Regarding Forward-Looking Statements This quarterly report contains forward-looking statements within the meaning of the federal securities laws. These include statements about our expectations, beliefs, intentions or strategies for the future, which we indicate by words or phrases such as "anticipate," "expect," "intend," "plan," "will," "we believe," "HSTC believes," "management believes" and similar language. The forward-looking statements are based on the current expectations of HSTC and are subject to certain risks, uncertainties and assumptions, including those set forth in the discussion under "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this report. The actual results may differ materially from results anticipated in these forward-looking statements. We base the forward-looking statements on information currently available to us, and we assume no obligation to update them. Investors are also advised to refer to the information in our filings with the Securities and Exchange Commission, especially on Forms 10-K, 10-Q and 8-K, in which we discuss in more detail various important factors that could cause actual results to differ from expected or historic results. It is not possible to foresee or identify all such factors. As such, investors should not consider any list of such factors to be an exhaustive statement of all risks and uncertainties or potentially inaccurate assumptions. Critical Accounting Policies and Estimates Our condensed financial statements and related public financial information are based on the

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.